News on Dextra Laboratories from BioPortfolio.com http://www.BioPortfolio.com Consolidated Dextra Laboratories news from BioPortfolio.com Wed, 10 Feb 2010 07:50:13 GMT en OlFactor Laboratories acquires exclusive license to patented technology from UC Riversidehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039853&HITNO=0&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dextra%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039853&THISHREF=http://c.moreover.com/click/here.pl%3fz2538431582%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039853&HITNO=0&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dextra%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039853&THISHREF=http://c.moreover.com/click/here.pl%3fz2538431582%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Enzyme Research: Research from Ranbaxy Research Laboratories in the area of enzyme research publishedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039749&HITNO=1&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dextra%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039749&THISHREF=http://c.moreover.com/click/here.pl%3fz2538357664%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039749&HITNO=1&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dextra%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039749&THISHREF=http://c.moreover.com/click/here.pl%3fz2538357664%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsRX: ICON names Tom O'Leary president, Central Laboratorieshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038180&HITNO=2&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dextra%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038180&THISHREF=http://c.moreover.com/click/here.pl%3fz2537520624%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038180&HITNO=2&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dextra%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038180&THISHREF=http://c.moreover.com/click/here.pl%3fz2537520624%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: UC Riverside licenses technology to OlFactor Laboratories, Inc.http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036440&HITNO=3&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dextra%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036440&THISHREF=http://c.moreover.com/click/here.pl%3fz2536619155%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036440&HITNO=3&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dextra%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036440&THISHREF=http://c.moreover.com/click/here.pl%3fz2536619155%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comResearch & Development: Updates for BioElectronics (OTC:BIEL), Borealis (OTC:BOREF), Charles River Laboratories (NYSE:CRL)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035380&HITNO=4&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dextra%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035380&THISHREF=http://c.moreover.com/click/here.pl%3fz2536218755%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035380&HITNO=4&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dextra%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035380&THISHREF=http://c.moreover.com/click/here.pl%3fz2536218755%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comLos Angeles Chronicle: Brookes Pharmaceutical Laboratories (Pakistan) Limited-Company Report - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034158&HITNO=5&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dextra%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034158&THISHREF=http://c.moreover.com/click/here.pl%3fz2535671318%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034158&HITNO=5&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dextra%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034158&THISHREF=http://c.moreover.com/click/here.pl%3fz2535671318%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: ICON promotes Tom OLearyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034126&HITNO=6&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dextra%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034126&THISHREF=http://c.moreover.com/click/here.pl%3fz2535647177%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034126&HITNO=6&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dextra%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034126&THISHREF=http://c.moreover.com/click/here.pl%3fz2535647177%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmafocus: Alliance Pharma to Buy Cambridge Laboratories for About $22.3Mhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033077&HITNO=7&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dextra%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033077&THISHREF=http://c.moreover.com/click/here.pl%3fz2534990477%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033077&HITNO=7&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dextra%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033077&THISHREF=http://c.moreover.com/click/here.pl%3fz2534990477%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: CRT and AstraZeneca form major alliance to create cancer metabolism drugshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033002&HITNO=8&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dextra%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033002&THISHREF=http://c.moreover.com/click/here.pl%3fz2534951817%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033002&HITNO=8&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dextra%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033002&THISHREF=http://c.moreover.com/click/here.pl%3fz2534951817%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCancer Research UK: Cipla retains top slot in domestic pharma markethttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032921&HITNO=9&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dextra%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032921&THISHREF=http://c.moreover.com/click/here.pl%3fz2534883814%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032921&HITNO=9&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dextra%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032921&THISHREF=http://c.moreover.com/click/here.pl%3fz2534883814%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBusiness Standard India: GlaxoSmithKline not to acquire 5% stake in Dr. Reddy's Laboratorieshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030805&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dextra%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030805&THISHREF=http://c.moreover.com/click/here.pl%3fz2533828695%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030805&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dextra%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030805&THISHREF=http://c.moreover.com/click/here.pl%3fz2533828695%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTradingMarkets: GlaxoSmithKline not to acquire 5% stake in Dr. Reddy's Laboratorieshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030786&HITNO=11&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dextra%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030786&THISHREF=http://c.moreover.com/click/here.pl%3fz2533819845%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030786&HITNO=11&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dextra%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030786&THISHREF=http://c.moreover.com/click/here.pl%3fz2533819845%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTradingMarkets: Alliance Pharma buys Cambridge Laboratorieshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029782&HITNO=12&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dextra%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029782&THISHREF=http://c.moreover.com/click/here.pl%3fz2533264603%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029782&HITNO=12&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dextra%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029782&THISHREF=http://c.moreover.com/click/here.pl%3fz2533264603%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBusiness Financial Newswire: Alliance Pharma gains 18 new prescription products in acquisitionhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028105&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dextra%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028105&THISHREF=http://c.moreover.com/click/here.pl%3fz2532586672%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028105&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dextra%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028105&THISHREF=http://c.moreover.com/click/here.pl%3fz2532586672%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comProactive Investors.co.uk: Atherosclerosis: Researchers from Gorlaeus Laboratories report on findings in atherosclerosishttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027480&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dextra%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027480&THISHREF=http://c.moreover.com/click/here.pl%3fz2532209409%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027480&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dextra%20Laboratories&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027480&THISHREF=http://c.moreover.com/click/here.pl%3fz2532209409%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsRX: